BioSupply Trends Quarterly logo
Search
Close this search box.

First Cancer Patients Receive mRNA Therapy in Clinical Trial

image of mRNA therapy

Imperial College Healthcare NHS Trust has enrolled the first United Kingdom (UK) patients who have received an experimental messenger RNA (mRNA) therapy — a type of immunotherapy treatment called mRNA-4359 — in its Phase I/II clinical trial.

FDA Expands Approval to wilate for Prophylaxis in All Types of VWDr

FDA Expands Approval to wilate for Prophylaxis in All Types of VWDr

Octapharma USA’s wilate, von Willebrand factor (VWF)/coagulation factor VIII complex (human) lyophilized power for solution for intravenous injection, has been given expanded approval by the U.S. Food and Drug Administration (FDA) for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children aged 6 and older with any type of von Willebrand disease (VWD).